View in EDS

AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial.

Saved in:
Bibliographic Details
Title: AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial.
Authors: Burza, Sakib1,2 sakib.burza@barcelona.msf.org, Mahajan, Raman1, Kazmi, Shahwar1, Alexander, Neal2, Kumar, Deepak1, Kumar, Vikash1, Lasry, Estrella1, Harshana, Amit1, Pereira, Alan de Lima1, Das, Pradeep3, Verma, Neena3, Das, Vidya Nand Ravi3, Lal, Chandra Shekhar3, Rewari, Bharat4, Goyal, Vishal5, Rijal, Suman5, Alves, Fabiana5, Gill, Naresh6, Pandey, Krishna3
Source: Clinical Infectious Diseases. 10/15/2022, Vol. 75 Issue 8, p1423-1432. 10p.
Database: Environment Complete
Description
ISSN:10584838
DOI:10.1093/cid/ciac127